These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37829649)

  • 1. Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9780837. PubMed ID: 37829649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.
    Xiao Y; Li S; Zhang M; Liu X; Ju G; Hou J
    Evid Based Complement Alternat Med; 2022; 2022():5490644. PubMed ID: 35722147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2022; 2022():9807439. PubMed ID: 36475012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9838460. PubMed ID: 38550156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9823636. PubMed ID: 37885864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9876715. PubMed ID: 37476339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9864232. PubMed ID: 37829402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9846548. PubMed ID: 37387965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: A Nomogram Predicting the Prognosis of Renal Cell Carcinoma Patients with Lung Metastases.
    International BR
    Biomed Res Int; 2023; 2023():9832720. PubMed ID: 38075299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9828737. PubMed ID: 37266270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values.
    Environmental And Public Health JO
    J Environ Public Health; 2023; 2023():9756067. PubMed ID: 38125879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9862864. PubMed ID: 37476775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9806284. PubMed ID: 37565158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] LncRNA GAS6 antisense RNA 1 facilitates the tumorigenesis of clear cell renal cell carcinoma by regulating the AMP‑activated protein kinase/mTOR signaling pathway.
    Guo X; Li H; Zhang M; Li R
    Oncol Lett; 2024 Mar; 27(3):126. PubMed ID: 38333641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9782763. PubMed ID: 37503422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9786174. PubMed ID: 38077938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
    International BR
    Biomed Res Int; 2024; 2024():9850107. PubMed ID: 38550181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: High SIRPA Expression Predicts Poor Prognosis and Correlates with Immune Infiltrates in Patients with Esophageal Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9758202. PubMed ID: 37860319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.